Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

    Results: 1 to 20 of 69

    1.

    Loss of SOX10 function contributes to the phenotype of human Merlin-null schwannoma cells.

    Doddrell RD, Dun XP, Shivane A, Feltri ML, Wrabetz L, Wegner M, Sock E, Hanemann CO, Parkinson DB.

    Brain. 2013 Feb;136(Pt 2):549-63. doi: 10.1093/brain/aws353.

    PMID:
    23413263
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification.

    Nicolas G, Pottier C, Maltête D, Coutant S, Rovelet-Lecrux A, Legallic S, Rousseau S, Vaschalde Y, Guyant-Maréchal L, Augustin J, Martinaud O, Defebvre L, Krystkowiak P, Pariente J, Clanet M, Labauge P, Ayrignac X, Lefaucheur R, Le Ber I, Frébourg T, Hannequin D, Campion D.

    Neurology. 2013 Jan 8;80(2):181-7. doi: 10.1212/WNL.0b013e31827ccf34. Epub 2012 Dec 19.

    PMID:
    23255827
    [PubMed - indexed for MEDLINE]
    3.

    PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas.

    Laimer D, Dolznig H, Kollmann K, Vesely PW, Schlederer M, Merkel O, Schiefer AI, Hassler MR, Heider S, Amenitsch L, Thallinger C, Staber PB, Simonitsch-Klupp I, Artaker M, Lagger S, Turner SD, Pileri S, Piccaluga PP, Valent P, Messana K, Landra I, Weichhart T, Knapp S, Shehata M, Todaro M, Sexl V, Höfler G, Piva R, Medico E, Ruggeri BA, Cheng M, Eferl R, Egger G, Penninger JM, Jaeger U, Moriggl R, Inghirami G, Kenner L.

    Nat Med. 2012 Nov;18(11):1699-704. doi: 10.1038/nm.2966. Epub 2012 Oct 14.

    PMID:
    23064464
    [PubMed - indexed for MEDLINE]
    4.

    World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management.

    Gotlib J.

    Am J Hematol. 2012 Sep;87(9):903-14. doi: 10.1002/ajh.23293.

    PMID:
    22926771
    [PubMed - indexed for MEDLINE]
    5.

    Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.

    Roberts KG, Morin RD, Zhang J, Hirst M, Zhao Y, Su X, Chen SC, Payne-Turner D, Churchman ML, Harvey RC, Chen X, Kasap C, Yan C, Becksfort J, Finney RP, Teachey DT, Maude SL, Tse K, Moore R, Jones S, Mungall K, Birol I, Edmonson MN, Hu Y, Buetow KE, Chen IM, Carroll WL, Wei L, Ma J, Kleppe M, Levine RL, Garcia-Manero G, Larsen E, Shah NP, Devidas M, Reaman G, Smith M, Paugh SW, Evans WE, Grupp SA, Jeha S, Pui CH, Gerhard DS, Downing JR, Willman CL, Loh M, Hunger SP, Marra MA, Mullighan CG.

    Cancer Cell. 2012 Aug 14;22(2):153-66. doi: 10.1016/j.ccr.2012.06.005.

    PMID:
    22897847
    [PubMed - indexed for MEDLINE]
    6.

    Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells.

    Dong Y, Han Q, Zou Y, Deng Z, Lu X, Wang X, Zhang W, Jin H, Su J, Jiang T, Ren H.

    Mol Cell Biochem. 2012 Nov;370(1-2):89-102. doi: 10.1007/s11010-012-1401-0. Epub 2012 Jul 25.

    PMID:
    22829019
    [PubMed - indexed for MEDLINE]
    7.

    Complete response of myeloid sarcoma with FIP1L1-PDGFRA -associated myeloproliferative neoplasms to imatinib mesylate monotherapy.

    Tang TC, Chang H, Chuang WY.

    Acta Haematol. 2012;128(2):83-7. doi: 10.1159/000338217. Epub 2012 Jun 19.

    PMID:
    22722648
    [PubMed - indexed for MEDLINE]
    8.

    Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity.

    Kim Y, Kim E, Wu Q, Guryanova O, Hitomi M, Lathia JD, Serwanski D, Sloan AE, Weil RJ, Lee J, Nishiyama A, Bao S, Hjelmeland AB, Rich JN.

    Genes Dev. 2012 Jun 1;26(11):1247-62. doi: 10.1101/gad.193565.112.

    PMID:
    22661233
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Incidence and clinical characteristics of myeloproliferative neoplasms displaying a PDGFRB rearrangement.

    Arefi M, García JL, Peñarrubia MJ, Queizán JA, Hermosín L, López-Corral L, Megido M, Giraldo P, de las Heras N, Vanegas RJ, Gutiérrez NC, Hernández-Rivas JM.

    Eur J Haematol. 2012 Jul;89(1):37-41. doi: 10.1111/j.1600-0609.2012.01799.x.

    PMID:
    22587685
    [PubMed - indexed for MEDLINE]
    10.

    De novo childhood myelodysplastic/myeloproliferative disease with unique molecular characteristics.

    Ismael O, Shimada A, Hama A, Elshazley M, Muramatsu H, Goto A, Sakaguchi H, Tanaka M, Takahashi Y, Yinyan X, Fukuda M, Miyajima Y, Yamashita Y, Horibe K, Hanada R, Ito M, Kojima S.

    Br J Haematol. 2012 Jul;158(1):129-37. doi: 10.1111/j.1365-2141.2012.09140.x. Epub 2012 May 10.

    PMID:
    22571758
    [PubMed - indexed for MEDLINE]
    11.

    Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.

    Smith CC, Wang Q, Chin CS, Salerno S, Damon LE, Levis MJ, Perl AE, Travers KJ, Wang S, Hunt JP, Zarrinkar PP, Schadt EE, Kasarskis A, Kuriyan J, Shah NP.

    Nature. 2012 Apr 15;485(7397):260-3. doi: 10.1038/nature11016.

    PMID:
    22504184
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    Congenital and childhood myeloproliferative disorders with eosinophilia responsive to imatinib.

    Abraham S, Salama M, Hancock J, Jacobsen J, Fluchel M.

    Pediatr Blood Cancer. 2012 Nov;59(5):928-9. doi: 10.1002/pbc.24148. Epub 2012 Apr 5.

    PMID:
    22488677
    [PubMed - indexed for MEDLINE]
    13.

    Suppression of PDGF-induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretion.

    Fitter S, Vandyke K, Gronthos S, Zannettino AC.

    J Mol Endocrinol. 2012 May 8;48(3):229-40. doi: 10.1530/JME-12-0003. Print 2012.

    PMID:
    22474082
    [PubMed - indexed for MEDLINE]
    Free Article
    14.

    Eosinophilic myeloid disorders.

    Noel P.

    Semin Hematol. 2012 Apr;49(2):120-7. doi: 10.1053/j.seminhematol.2012.01.008. Review.

    PMID:
    22449622
    [PubMed - indexed for MEDLINE]
    15.

    Local medial microenvironment directs phenotypic modulation of smooth muscle cells after experimental renal transplantation.

    Boersema M, Katta K, Rienstra H, Molema G, Nguyen TQ, Goldschmeding R, Navis G, van den Born J, Popa ER, Hillebrands JL.

    Am J Transplant. 2012 Jun;12(6):1429-40. doi: 10.1111/j.1600-6143.2012.04001.x. Epub 2012 Mar 15.

    PMID:
    22420764
    [PubMed - indexed for MEDLINE]
    16.

    CD99 is a novel prognostic stromal marker in non-small cell lung cancer.

    Edlund K, Lindskog C, Saito A, Berglund A, Pontén F, Göransson-Kultima H, Isaksson A, Jirström K, Planck M, Johansson L, Lambe M, Holmberg L, Nyberg F, Ekman S, Bergqvist M, Landelius P, Lamberg K, Botling J, Ostman A, Micke P.

    Int J Cancer. 2012 Nov 15;131(10):2264-73. doi: 10.1002/ijc.27518. Epub 2012 Apr 24.

    PMID:
    22392539
    [PubMed - indexed for MEDLINE]
    17.

    Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes.

    Chang H, Chuang WY, Sun CF, Barnard MR.

    Diagn Pathol. 2012 Feb 22;7:19. doi: 10.1186/1746-1596-7-19.

    PMID:
    22356850
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    PDGFRβ expression and function in fibroblasts derived from pluripotent cells is linked to DNA demethylation.

    Hewitt KJ, Shamis Y, Knight E, Smith A, Maione A, Alt-Holland A, Sheridan SD, Haggarty SJ, Garlick JA.

    J Cell Sci. 2012 May 1;125(Pt 9):2276-87. doi: 10.1242/jcs.099192. Epub 2012 Feb 17.

    PMID:
    22344267
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Phase II study of imatinib in advanced chordoma.

    Stacchiotti S, Longhi A, Ferraresi V, Grignani G, Comandone A, Stupp R, Bertuzzi A, Tamborini E, Pilotti S, Messina A, Spreafico C, Gronchi A, Amore P, Vinaccia V, Casali PG.

    J Clin Oncol. 2012 Mar 20;30(9):914-20. doi: 10.1200/JCO.2011.35.3656. Epub 2012 Feb 13.

    PMID:
    22331945
    [PubMed - indexed for MEDLINE]
    20.

    PDGFRA promoter polymorphisms are associated with the risk of papillary thyroid cancer.

    Kim MJ, Kim SK, Park HJ, Chung DH, Park HK, Lee JS, Kwon KH, Chung JH.

    Mol Med Rep. 2012 May;5(5):1267-70. doi: 10.3892/mmr.2012.784. Epub 2012 Feb 10.

    PMID:
    22327316
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk